Vaccine Delivery Devices Market Report 2026

Vaccine Delivery Devices Market Overview

• Vaccine Delivery Devices market size has reached to $7.01 billion in 2025 • Expected to grow to $10.9 billion in 2030 at a compound annual growth rate (CAGR) of 9% • Growth Driver: The Rising Prevalence Of Infectious Diseases Fueling Market Growth Due To Increasing Global Transmission Risks • Market Trend: Innovations In Prefillable Syringe Technology Enhance Safety, Reliability, And Efficiency In Vaccine Administration • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Vaccine Delivery Devices Market?

Vaccine delivery devices are tools or systems designed to administer vaccines safely and effectively to individuals. These devices are designed to ensure accurate dosage, proper delivery, and minimal discomfort for the patient. Vaccine delivery devices play a crucial role in public health efforts by facilitating the distribution and administration of vaccines to prevent infectious diseases. The main types of vaccine delivery devices are needle-free injection systems, oral delivery systems, nasal delivery systems, jet injectors, microneedle patches, and microinjectors. Needle-free injection systems are medical devices that deliver medication through the skin without using a traditional needle. It involves various routes of administration such as intradermal vaccination, intramuscular vaccination, subcutaneous vaccination, and others. It is used by various end-users such as hospitals, clinics, and others.

What Is The Vaccine Delivery Devices Market Growth Forecast?

The vaccine delivery devices market size is expected to see strong growth in the next few years. It will grow to $10.9 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to increasing development of next-generation vaccines, rising demand for self-administration devices, expansion of pandemic preparedness programs, growing investments in vaccine accessibility technologies, increased focus on dose accuracy and compliance. Major trends in the forecast period include increasing adoption of needle-free injection technologies, rising demand for microneedle patch delivery systems, growing use of alternative vaccine administration routes, expansion of mass immunization programs, enhanced focus on patient comfort and safety.

Global Vaccine Delivery Devices Market Segmentation

1) By Type Of Device: Needle Free Injection Systems, Oral Delivery Systems, Nasal Delivery Systems, Jet Injectors, Microneedle Patches And Microinjectors 2) By Route Of Administration: Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination, Other Vaccinations 3) By End Users: Hospitals, Clinics, Other End Users Subsegments: 1) By Needle Free Injection Systems: Spring-Based Injectors, Gas-Driven Injectors, Hybrid Injectors 2) By Oral Delivery Systems: Oral Tablets And Capsules, Oral Sprays, Oral Solutions 3) By Nasal Delivery Systems: Nasal Sprays, Nasal Drops, Nasal Powder Systems 4) By Jet Injectors: Pneumatic Jet Injectors, Electromechanical Jet Injectors 5) By Microneedle Patches And Microinjectors: Dissolvable Microneedles, Solid Microneedles, Microinjector Devices

What Is The Driver Of The Vaccine Delivery Devices Market?

The growing prevalence of infectious diseases is expected to propel the growth of the vaccine delivery devices market going forward. Infectious diseases are illnesses caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites that can spread between individuals, animals, or through contaminated environments. The rise in infectious diseases is driven by factors such as rapid urbanization, increased international travel, climate-related ecological changes, and expanding population density, all of which facilitate the transmission of pathogens. Vaccine delivery devices support public health by enabling efficient and safe administration of vaccines, strengthening immunity within communities, and reducing the spread of infectious agents. For instance, in November 2024, according to the World Health Organization (WHO), a Switzerland-based specialized agency of the United Nations responsible for global public health, there were an estimated 10.3 million measles cases worldwide in 2023, representing a 20% increase compared to 2022. Therefore, the increasing prevalence of infectious diseases is driving the growth of the vaccine delivery devices industry.

Key Players In The Global Vaccine Delivery Devices Market

Major companies operating in the vaccine delivery devices market are Johnson & Johnson, Sanofi S.A., 3M Company, GlaxoSmithKline plc, Becton Dickinson and Company, INOVIO Pharmaceuticals Inc., Terumo Corporation, SCHOTT AG, Vaxxas Inc., PharmaJet Inc., Enesi Pharma Limited, NanoPass Technologies Ltd., Gerresheimer AG, West Pharmaceutical Services Inc., Nemera, SHL Medical AG, Portal Instruments Inc., ApiJect Systems Corp., Credence MedSystems Inc., Zosano Pharma Corporation

Global Vaccine Delivery Devices Market Trends and Insights

Major companies operating in the vaccine delivery devices market are focusing on developing advanced solutions, such as innovative intradermal delivery systems, to enhance vaccine efficiency and reduce wastage. An intradermal delivery system refers to a technology designed to deposit vaccines directly into the dermal layer, where abundant immune cells help trigger stronger immunogenic responses while using lower vaccine volumes. For instance, in July 2025, Terumo Corporation, a Japan-based medical technology company, introduced the Immucise Intradermal Injection System, a vertical-puncture device equipped with a 33G needle that ensures precise intradermal delivery. This innovation helps achieve consistent wheal formation with minimal leakage, improves the accuracy of intradermal injections compared to the traditional Mantoux technique, and enables a significant reduction in vaccine dosage requirements. By supporting stronger immunogenicity, optimizing resource use, and reducing operational challenges, the Immucise system enhances vaccination efficiency and helps streamline healthcare procedures.

What Are Latest Mergers And Acquisitions In The Vaccine Delivery Devices Market?

In March 2024, Sharps Technology Inc., a US-based medical device company partnered with Roncadelle Operations to expand high-precision syringe manufacturing capabilities and strengthen global supply capacity for next-generation vaccine-delivery solutions. Through this partnership, Sharps aims to advance the development of next-generation prefillable syringe systems and custom auto-injector components while expanding domestic manufacturing capabilities in the United States. Roncadelle Operations s.r.l. is a Itlay-based company that provide vaccine (and more generally injectable drug) delivery devices.

Regional Outlook

North America was the largest region in the vaccine delivery devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Vaccine Delivery Devices Market?

The vaccine delivery devices market consists of sales of auto-injectors, jet injectors, microneedle patches, oral vaccine delivery, transdermal patches, inhalers, and intradermal devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.